Esperion Therapeutics, Inc. short interest in 2024
In 2024, Esperion Therapeutics, Inc.'s disclosed short interest ran from 17.76% of shares outstanding on 12 Jan 2024 to 16.42% on 31 Dec 2024, a change of -1.34 percentage points. The year's high was 21.27% on 15 Aug 2024 and its low 9.16% on 29 Feb 2024, averaging 15.13% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.36 days on 13 Sep 2024. Full history: Esperion Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 17.76% (12 Jan 2024)
- End of year
- 16.42% (31 Dec 2024)
- Change
- -1.34 pp
- High
- 21.27% (15 Aug 2024)
- Low
- 9.16% (29 Feb 2024)
- Average
- 15.13%
- Highest days to cover
- 13.36 (13 Sep 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 17.76% | 2.65 | results (8-K) |
| 31 Jan 2024 | 17.65% | 2.54 | |
| 15 Feb 2024 | 10.03% | 4.25 | |
| 29 Feb 2024 | 9.16% | 3.39 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 9.55% | 4.63 | |
| 28 Mar 2024 | 10.77% | 2.07 | |
| 15 Apr 2024 | 10.05% | 2.02 | |
| 30 Apr 2024 | 10.74% | 4.07 | |
| 15 May 2024 | 13.15% | 2.49 | 10-Q filed, results (8-K) |
| 31 May 2024 | 11.55% | 3.26 | |
| 14 Jun 2024 | 13.14% | 2.87 | |
| 28 Jun 2024 | 12.43% | 1.83 | |
| 15 Jul 2024 | 20.80% | 5.49 | |
| 31 Jul 2024 | 20.13% | 8.44 | |
| 15 Aug 2024 | 21.27% | 7.69 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 20.61% | 11.80 | |
| 13 Sep 2024 | 19.41% | 13.36 | |
| 30 Sep 2024 | 19.09% | 12.75 | |
| 15 Oct 2024 | 18.03% | 9.76 | |
| 31 Oct 2024 | 17.05% | 11.87 | |
| 15 Nov 2024 | 15.86% | 4.86 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 15.48% | 6.30 | |
| 13 Dec 2024 | 12.93% | 2.08 | |
| 31 Dec 2024 | 16.42% | 7.20 |
See also: Esperion Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.